Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 24, 2015, 75 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $542.19 to $168,250,000.00.

Highlighted Stocks Traded by Insiders:

Universal (UVV) - FREE Research Report

Adams John B Jr, who is Director at Universal, sold 1,377 shares at $47.55 on Feb. 24, 2015. Following this transaction, the Director owned 16,625 shares meaning that the stake was reduced by 7.65% with the 1,377-share transaction.

The shares most recently traded at $47.39, down $0.16, or 0.34% since the insider transaction. Historical insider transactions for Universal go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 3,000
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 3,000
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 3,000

The average volume for Universal has been 301,900 shares per day over the past 30 days. Universal has a market cap of $1.1 billion and is part of the consumer goods sector and tobacco industry. Shares are up 8.53% year-to-date as of the close of trading on Tuesday.

Universal Corporation operates as a leaf tobacco merchant and processor worldwide. It is engaged in procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products. The stock currently has a dividend yield of 4.4%. The company has a P/E ratio of 14.0. Currently, there are no analysts who rate Universal a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UVV - FREE

TheStreet Quant Ratings

rates Universal as a

buy

. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Universal Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Chase (CCF) - FREE Research Report

Gack Lewis P, who is Director at Chase, sold 200 shares at $42.74 on Feb. 24, 2015. Following this transaction, the Director owned 10,154 shares meaning that the stake was reduced by 1.93% with the 200-share transaction.

Chase Mary Claire, who is Director at Chase, sold 200 shares at $42.63 on Feb. 24, 2015. Following this transaction, the Director owned 5,951 shares meaning that the stake was reduced by 3.25% with the 200-share transaction.

The shares most recently traded at $43.39, up $0.76, or 1.75% since the insider transaction. Historical insider transactions for Chase go as follows:

  • 4-Week # shares sold: 1,100
  • 12-Week # shares sold: 1,100
  • 24-Week # shares sold: 1,300

The average volume for Chase has been 12,300 shares per day over the past 30 days. Chase has a market cap of $391.3 million and is part of the industrial goods sector and industrial industry. Shares are up 18.51% year-to-date as of the close of trading on Monday.

Chase Corporation manufactures and sells protective materials for various applications in the United States and internationally. It operates in two segments, Industrial Materials and Construction Materials. The stock currently has a dividend yield of 1.4%. The company has a P/E ratio of 16.1. Currently, there are no analysts who rate Chase a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CCF - FREE

TheStreet Quant Ratings

rates Chase as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Chase Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Pebblebrook Hotel (PEB) - FREE Research Report

Jackson Ron E., who is Director at Pebblebrook Hotel, bought 1,167 shares at $48.45 on Feb. 24, 2015. Following this transaction, the Director owned 27,000 shares meaning that the stake was boosted by 4.52% with the 1,167-share transaction.

The shares most recently traded at $48.89, up $0.44, or 0.9% since the insider transaction. Historical insider transactions for Pebblebrook Hotel go as follows:

  • 4-Week # shares sold: 1,490
  • 12-Week # shares sold: 1,490
  • 24-Week # shares sold: 1,490

The average volume for Pebblebrook Hotel has been 502,300 shares per day over the past 30 days. Pebblebrook Hotel has a market cap of $3.6 billion and is part of the financial sector and real estate industry. Shares are up 6.22% year-to-date as of the close of trading on Tuesday.

Pebblebrook Hotel Trust, through Pebblebrook Hotel, L.P., operates as a real estate investment trust. The company acquires and invests primarily in hotel properties located in the United States. The stock currently has a dividend yield of 1.85%. The company has a P/E ratio of 70.0. Currently, there are 5 analysts who rate Pebblebrook Hotel a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PEB - FREE

TheStreet Quant Ratings

rates Pebblebrook Hotel as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

Pebblebrook Hotel Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null